Your browser doesn't support javascript.
loading
Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action.
Boot, Maikel; Commandeur, Susanna; Subudhi, Amit K; Bahira, Meriem; Smith, Trever C; Abdallah, Abdallah M; van Gemert, Mae; Lelièvre, Joël; Ballell, Lluís; Aldridge, Bree B; Pain, Arnab; Speer, Alexander; Bitter, Wilbert.
Afiliação
  • Boot M; Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
  • Commandeur S; Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
  • Subudhi AK; Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.
  • Bahira M; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Smith TC; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Abdallah AM; Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.
  • van Gemert M; Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
  • Lelièvre J; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Ballell L; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Aldridge BB; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Pain A; Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia.
  • Speer A; Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
  • Bitter W; Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands w.bitter@vumc.nl.
Antimicrob Agents Chemother ; 62(7)2018 07.
Article em En | MEDLINE | ID: mdl-29661879
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Mycobacterium marinum / Descoberta de Drogas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Mycobacterium marinum / Descoberta de Drogas / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda